Baidu
map

2013ASH/ISH高血压管理指南

2013-12-24 箫砚 dxy

整体治疗目标:高血压治疗的目标是控制血压水平,并控制其他的高危因素,比如心血管疾病风险包括血脂紊乱、葡萄糖耐受或糖尿病、肥胖以及吸烟等。对于高血压患者,收缩压的治疗目标通常低于140 mm Hg,舒张压通常低于90 mm Hg。此前,也有一些指南推荐,对于患有糖尿病、慢性肾脏疾病以及冠脉疾病的患者,血压治疗目标值应为<130/80 mm Hg,但是目前没有足够的证据支持这一目标水平。因此,尽

编者按:ASH/ISH高血压管理指南旨在为高血压治疗提供一个方便快捷的管理流程。指南制定专家组指出,这项指南不仅是为初级护理医生和医学生提供指导,也是为所有一线专业人员制定。该指南提供了高血压管理流程图、不同高血压患者用药策略以及高血压常用药物推荐剂量。 高血压管理流程图: 图1,高血压管理流程图 不同高血压患者用药策略: 表1,不同高血压患者用药策略 高血压常用药物推荐剂量: 表2,高血压常用药物推荐剂量 整体治疗目标: 高血压治疗的目标是控制血压水平,并控制其他的高危因素,比如心血管疾病风险包括血脂紊乱、葡萄糖耐受或糖尿病、肥胖以及吸烟等。 对于高血压患者,收缩压的治疗目标通常低于140 mm Hg,舒张压通常低于90 mm Hg。此前,也有一些指南推荐,对于患有糖尿病、慢性肾脏疾病以及冠脉疾病的患者,血压治疗目标值应为<130/80 mm Hg,但是目前没有足够的证据支持这一目标水平。因此,尽管一些专家仍然推荐对于罹患慢性肾脏疾病同时合并蛋白尿的患者,血压治疗目标值应为<130/80 mm Hg,但是目前广泛推荐的治疗目标值还是<140/ 90 mm Hg。【

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1946128, encodeId=9ae91946128c1, content=<a href='/topic/show?id=f6fb102e02e4' target=_blank style='color:#2F92EE;'>#高血压管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102702, encryptionId=f6fb102e02e4, topicName=高血压管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Tue Jan 21 22:41:00 CST 2014, time=2014-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936264, encodeId=5aa419362640d, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Tue Feb 04 02:41:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301103, encodeId=fe1d1301103ce, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2852, encryptionId=38e32852fe, topicName=ASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Thu Dec 26 08:41:00 CST 2013, time=2013-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344292, encodeId=d24a134429209, content=<a href='/topic/show?id=683a88964b0' target=_blank style='color:#2F92EE;'>#血压管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88964, encryptionId=683a88964b0, topicName=血压管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=793a2500200, createdName=12498e5fm12(暂无昵称), createdTime=Thu Dec 26 08:41:00 CST 2013, time=2013-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6453, encodeId=390f64532b, content=CCB类是什么药, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=孙景河, createdTime=Wed Dec 25 11:58:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6452, encodeId=59286452e9, content=CCB类是什么药, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=孙景河, createdTime=Wed Dec 25 11:56:00 CST 2013, time=2013-12-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1946128, encodeId=9ae91946128c1, content=<a href='/topic/show?id=f6fb102e02e4' target=_blank style='color:#2F92EE;'>#高血压管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102702, encryptionId=f6fb102e02e4, topicName=高血压管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Tue Jan 21 22:41:00 CST 2014, time=2014-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936264, encodeId=5aa419362640d, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Tue Feb 04 02:41:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301103, encodeId=fe1d1301103ce, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2852, encryptionId=38e32852fe, topicName=ASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Thu Dec 26 08:41:00 CST 2013, time=2013-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344292, encodeId=d24a134429209, content=<a href='/topic/show?id=683a88964b0' target=_blank style='color:#2F92EE;'>#血压管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88964, encryptionId=683a88964b0, topicName=血压管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=793a2500200, createdName=12498e5fm12(暂无昵称), createdTime=Thu Dec 26 08:41:00 CST 2013, time=2013-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6453, encodeId=390f64532b, content=CCB类是什么药, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=孙景河, createdTime=Wed Dec 25 11:58:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6452, encodeId=59286452e9, content=CCB类是什么药, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=孙景河, createdTime=Wed Dec 25 11:56:00 CST 2013, time=2013-12-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1946128, encodeId=9ae91946128c1, content=<a href='/topic/show?id=f6fb102e02e4' target=_blank style='color:#2F92EE;'>#高血压管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102702, encryptionId=f6fb102e02e4, topicName=高血压管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Tue Jan 21 22:41:00 CST 2014, time=2014-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936264, encodeId=5aa419362640d, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Tue Feb 04 02:41:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301103, encodeId=fe1d1301103ce, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2852, encryptionId=38e32852fe, topicName=ASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Thu Dec 26 08:41:00 CST 2013, time=2013-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344292, encodeId=d24a134429209, content=<a href='/topic/show?id=683a88964b0' target=_blank style='color:#2F92EE;'>#血压管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88964, encryptionId=683a88964b0, topicName=血压管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=793a2500200, createdName=12498e5fm12(暂无昵称), createdTime=Thu Dec 26 08:41:00 CST 2013, time=2013-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6453, encodeId=390f64532b, content=CCB类是什么药, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=孙景河, createdTime=Wed Dec 25 11:58:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6452, encodeId=59286452e9, content=CCB类是什么药, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=孙景河, createdTime=Wed Dec 25 11:56:00 CST 2013, time=2013-12-25, status=1, ipAttribution=)]
    2013-12-26 kksonne
  4. [GetPortalCommentsPageByObjectIdResponse(id=1946128, encodeId=9ae91946128c1, content=<a href='/topic/show?id=f6fb102e02e4' target=_blank style='color:#2F92EE;'>#高血压管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102702, encryptionId=f6fb102e02e4, topicName=高血压管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Tue Jan 21 22:41:00 CST 2014, time=2014-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936264, encodeId=5aa419362640d, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Tue Feb 04 02:41:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301103, encodeId=fe1d1301103ce, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2852, encryptionId=38e32852fe, topicName=ASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Thu Dec 26 08:41:00 CST 2013, time=2013-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344292, encodeId=d24a134429209, content=<a href='/topic/show?id=683a88964b0' target=_blank style='color:#2F92EE;'>#血压管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88964, encryptionId=683a88964b0, topicName=血压管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=793a2500200, createdName=12498e5fm12(暂无昵称), createdTime=Thu Dec 26 08:41:00 CST 2013, time=2013-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6453, encodeId=390f64532b, content=CCB类是什么药, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=孙景河, createdTime=Wed Dec 25 11:58:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6452, encodeId=59286452e9, content=CCB类是什么药, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=孙景河, createdTime=Wed Dec 25 11:56:00 CST 2013, time=2013-12-25, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1946128, encodeId=9ae91946128c1, content=<a href='/topic/show?id=f6fb102e02e4' target=_blank style='color:#2F92EE;'>#高血压管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102702, encryptionId=f6fb102e02e4, topicName=高血压管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Tue Jan 21 22:41:00 CST 2014, time=2014-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936264, encodeId=5aa419362640d, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Tue Feb 04 02:41:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301103, encodeId=fe1d1301103ce, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2852, encryptionId=38e32852fe, topicName=ASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Thu Dec 26 08:41:00 CST 2013, time=2013-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344292, encodeId=d24a134429209, content=<a href='/topic/show?id=683a88964b0' target=_blank style='color:#2F92EE;'>#血压管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88964, encryptionId=683a88964b0, topicName=血压管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=793a2500200, createdName=12498e5fm12(暂无昵称), createdTime=Thu Dec 26 08:41:00 CST 2013, time=2013-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6453, encodeId=390f64532b, content=CCB类是什么药, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=孙景河, createdTime=Wed Dec 25 11:58:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6452, encodeId=59286452e9, content=CCB类是什么药, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=孙景河, createdTime=Wed Dec 25 11:56:00 CST 2013, time=2013-12-25, status=1, ipAttribution=)]
    2013-12-25 孙景河

    CCB类是什么药

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1946128, encodeId=9ae91946128c1, content=<a href='/topic/show?id=f6fb102e02e4' target=_blank style='color:#2F92EE;'>#高血压管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102702, encryptionId=f6fb102e02e4, topicName=高血压管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Tue Jan 21 22:41:00 CST 2014, time=2014-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936264, encodeId=5aa419362640d, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Tue Feb 04 02:41:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301103, encodeId=fe1d1301103ce, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2852, encryptionId=38e32852fe, topicName=ASH)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39a0295, createdName=kksonne, createdTime=Thu Dec 26 08:41:00 CST 2013, time=2013-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344292, encodeId=d24a134429209, content=<a href='/topic/show?id=683a88964b0' target=_blank style='color:#2F92EE;'>#血压管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88964, encryptionId=683a88964b0, topicName=血压管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=793a2500200, createdName=12498e5fm12(暂无昵称), createdTime=Thu Dec 26 08:41:00 CST 2013, time=2013-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6453, encodeId=390f64532b, content=CCB类是什么药, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=孙景河, createdTime=Wed Dec 25 11:58:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6452, encodeId=59286452e9, content=CCB类是什么药, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=孙景河, createdTime=Wed Dec 25 11:56:00 CST 2013, time=2013-12-25, status=1, ipAttribution=)]
    2013-12-25 孙景河

    CCB类是什么药

    0

相关资讯

随刊述评三:高血压管理指南更新的推荐、回顾和责任

美国预防、检测、评估和治疗高血压委员会(JNC)第8次报告被业界称为“JNC Late”。12月18日,《美国医学会杂志》(JAMA)在线发表了JNC 8专家组成员报告《2014成人高血压管理指南》(要点)。其中该权威杂志还发表了随刊述评。 下载述评原文 3:Updated Guidelines for Management of High Blood Pressu

Baidu
map
Baidu
map
Baidu
map